USX:STRO - Sutro Biopharma Inc Sutro Biopharma Inc
Sector: Health Care, Industry: Biotechnology
Next Earnings: 14 Mar 2022
Add to Watchlist
Add Alert 

Yahoo Finance (Live Price)

USD 15.56    -0.680 (-4.19%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

3 Dec 2021



CEO: Mr. William J. Newell

IPO: 2018-09-27

Headquarters: US

Employees: 218



Sutro Biopharma Inc is a clinical stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.